Both in Pharmaceuticals
Veru vs Grace Therapeutics
Over the past year VERU returned −18.7% and GRCE returned −40.8%; their daily moves had a correlation of 0.07.
VERU −18.7% GRCE −40.8%Growth of $1, one year, split-adjusted
| Metric | VERU | GRCE |
|---|---|---|
| Price | $2.11 | $1.84 |
| Market cap | $36.1M | $38.7M |
| Today | −2.11% | +1.66% |
| 1 month | −17.1% | −10.7% |
| 6 months | −4.3% | −21.0% |
| Year to date | −1.2% | −46.8% |
| 1 year | −28.3% | −41.7% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $25.8M | $13.8M |
| Dividend yield | — | — |
| Volatility (60d) | 52.6% | 43.8% |
| Short % of float | 10.1% | 11.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).